- Patients with diabetes have high prevalence of diabetes-specific worries during the COVID-19 pandemic.
Why this matters
- Little is known about how worldwide pandemics affect psychosocial health of people with diabetes.
- Cross-sectional survey via online questionnaire completed by 1396 adults with diabetes (34.6% type 1; 61.6% type 2; 3.8% other).
- Funding: None disclosed.
- The most frequent worries:
- Being overly affected by COVID-19 because of diabetes: 56%.
- Being characterized as an at-risk group: 39%.
- Inability to manage diabetes with COVID-19: 28%.
- Reduced access to diabetes medications (24%) or equipment (17%).
- Worry about being overly affected was greater (ORs; 95% CIs) among:
- Women vs men: 1.6 (1.3-2.1); and
- Those with moderate-high distress levels: 4.9 (3.2-7.5).
- It was lower with type 2 vs type 1 diabetes: 0.6 (0.5-0.8).
- Worry about being unable to manage diabetes with COVID-19 was greater among:
- Women: 1.7 (1.3-2.1); and
- Those with diabetes complications: 1.4 (1.2-1.8).
- Individuals with worries:
- Checked blood glucose more often: 1.6-1.7 (1.0-2.6);
- Were more aware of medication taking: 2.3-3.0 (1.3-4.9); and
- Exercised more than usual: 1.3-1.7 (1.0-2.2).
- Convenience sample, may be healthier than average.